ReviewOncotarget2016
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
Elisabetta Fratta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewOncotarget2016
Elisabetta Fratta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.